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0929-6646/Copyright ª 2015, ElsevierBackground/Purpose: Oral submucous fibrosis (OSF) is a chronic progressive scaring oral dis-
ease associated with areca quid chewing. This study evaluated whether OSF patients had ane-
mia, hematinic deficiencies, and serum gastric parietal cell antibody (GPCA) positivity.
Methods: The blood hemoglobin (Hb), iron, vitamin B12, and folic acid concentrations, mean
corpuscular volume, and serum GPCA in 68 male OSF patients were measured and compared
with the corresponding data in 136 age-matched male healthy control individuals.
Results: We found that five (7.4%), 14 (20.6%), 34 (50.0%), 28 (41.2%), and nine (13.2%) of the
68 male OSF patients had Hb (< 13 g/dL), iron ( 70 mg/dL), vitamin B12 ( 450 pg/mL), and
folic acid ( 6 ng/mL) deficiencies, and serum GPCA positivity, respectively. Furthermore, OSF
patients had a significantly higher frequency of Hb (pZ 0.006), vitamin B12 (p < 0.001), or folic
acid (p < 0.001) deficiency and of serum GPCA positivity (pZ 0.011) than healthy control par-
ticipants. Of the five OSF patients with anemia, two had thalassemia trait, one had iron defi-
ciency anemia, and two had macrocytic anemia (mean corpuscular volume  100 fL). In
addition, of the nine OSF patients with serum GPCA positivity, six had vitamin B12 deficiency,
five had folic acid deficiency, and two had iron deficiency. However, none of the nine GPCA-
positive OSF patients had pernicious anemia based on the strict World Health Organization
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ciencies and of serum GPCA positivity in our male OSF patients.
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Oral submucous fibrosis (OSF) is a chronic progressive
scaring oral disease predominantly affecting people of
South Asian origin.1e3 It is characterized by juxtaepithelial
inflammatory cell infiltration followed by fibrosis in the
lamina propria, submucosa, and superficial muscle layer of
the oral mucosa. Epidemiologic studies have suggested the
habit of areca quid chewing as a major etiologic factor of
OSF.1e3 In Taiwan, there are 2 million people who have the
areca quid chewing habit.4 Previous studies have demon-
strated that all the OSF patients in Taiwan have the areca
quid chewing habit.5,6 Although the pathogenesis of OSF has
so far been unclear, previous studies have suggested that
the occurrence of OSF may be attributable to increased
production of collagen and reduced degradation of collagen
in the subepithelial connective tissue of the oral
mucosa.7e30 The areca nut alkaloids can stimulate the
fibroblast proliferation and collagen synthesis.7 Cytokines
and growth factors produced by inflammatory cells within
the OSF tissues may promote fibrosis by inducing prolifer-
ation of fibroblasts, upregulating collagen synthesis, and
downregulating collagenase production.8e12 Copper in
areca nut can upregulate collagen production in oral fi-
broblasts.13,14 Colligin/heat shock protein 47 produced by
arecoline-stimulated human buccal fibroblasts can increase
the processing and/or secretion of procollagen.15,16
The collagen deposition in the subepithelial connective
tissue of oral mucosa may also contribute to the reduced
collagen degradation. Previous studies showed a lower
collagenase activity in OSF lesional mucosa than in normal
oral mucosa and 3e5-fold lower levels of endogenous
collagenase activities in OSF tissues compared with normal
oral mucosa,17 as well as more tissue inhibitor of
metalloproteinase-1 protein production,18e20 higher type I
plasminogen activator inhibitor expression,21,22 and less
collagen phagocytosis activity in OSF than in normal oral
mucosal fibroblasts.23,24 Reduced collagen degradation can
also be attributable to synthesis of structure-stable
collagen type I trimer by OSF fibroblasts25 and stabiliza-
tion of collagen structure by areca nut polyphenolic com-
pounds (catechin and tannin),26,27 lysyl oxidase in OSF
tissues,28,29 or transglutaminase-2 produced by arecoline-
stimulated fibroblasts.30
In our oral mucosal disease clinic, patients with OSF
are sometimes encountered. Because the majority of
OSF patients cannot tolerate spicy food, suffer from
burning sensation of oral mucosa, and have a certain
degree of mouth opening limitation, these functional
impairments may affect normal food intake and lead to
nutritional deficiencies. In this study, data on 68 male
OSF patients were retrospectively collected from our
oral mucosal disease clinic. The blood hemoglobin (Hb),mean corpuscular volume (MCV), and serum iron,
vitamin B12, folic acid, and gastric parietal cell antibody
(GPCA) levels were examined and compared with the
corresponding data in 136 age-matched male healthy
control participants. We tried to find whether male OSF
patients might have higher frequencies of anemia; of
serum iron, vitamin B12, and folic acid deficiencies; and
of serum GPCA positivity than age-matched healthy
male control individuals.Materials and methods
Participants
Sixty-eight male OSF patients (mean age 38.7  11.2 years,
range 18e61 years) were enrolled in the study. For each
patient, two age-matched ( 2 years of each patient’s age)
healthy male control individuals were selected. Thus, the
normal control group consisted of 136 healthy male control
individuals (mean age 38.2  10.3 years, range 19e60
years). All the OSF patients and healthy control individuals
were seen consecutively, diagnosed, treated, and selected
in the oral mucosal disease clinic or dental clinic of National
Taiwan University Hospital (NTUH; Taipei, Taiwan) from
July 2007 to June 2014. Clinical diagnosis of OSF was made
when patients showed characteristic features of OSF,
including intolerance to spicy foods, blanching and stiffness
of the oral mucosa, fibrous bands in the buccal mucosa, and
progressive inability to open the mouth.5,6 Some OSF pa-
tients might also have a burning sensation in the mouth,
xerostomia, the presence of vesicles or ulcers on the oral
mucosa, depapillation of the tongue, and impaired tongue
mobility.5,6 Incisional biopsy of buccal mucosa was taken
from 20 of 68 OSF patients. Histological diagnosis was made
based on the examination of hematoxylin and eosin-stained
tissue sections. The histological criteria for a diagnosis of
OSF were: (1) atrophic epithelium with either parakeratosis
or hyperkeratosis, and (2) moderate to marked fibrosis or
hyalinization in the lamina propria, submucosa, and su-
perficial muscle layer.5,6 The oral mucosal sites (soft pal-
ate, retromolar area, buccal mucosa, labial mucosa, floor
of the mouth, and tongue) of involvement and the
maximum mouth opening (MMO) of OSF patients were
recorded. The severity of OSF was determined according to
the sites of involvement or MMO; the more the sites
involved and the less the MMO, the more severe the OSF. No
patient with mild OSF was included in the study, because all
our OSF patients had at least three sites of involvement.
None of the OSF patients had any systemic diseases, auto-
immune diseases (such as systemic lupus erythematosus,
rheumatoid arthritis, Sjogren’s syndrome, pemphigus vul-
garis, and cicatricial pemphigoid), inflammatory diseases,
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had dental caries, pulpal disease, malocclusion, or missing
of teeth but did not have any oral mucosal or systemic
diseases. None of our OSF patients had taken any pre-
scription medication at least 3 months prior to entering the
study.
All 68 OSF patients had areca quid chewing habit; they
chewed 1e120 (mean, 23) quids/d for 1e38 (mean, 14)
years. Fifty (73.5%) OSF patients claimed that they swal-
lowed some of the “juice” of areca quid during the chewing
process. Sixty-four (94.1%) of the 68 OSF patients were
smokers; they smoked from five to 60 (mean, 22) ciga-
rettes/d for 2e38 (mean, 18) years. Forty-five (66.2%) of
the 68 OSF patients were drinkers; they drank 45e6528
(mean, 938) g of pure alcohol per week for 1e32 (mean, 13)
years. Of the 136 healthy control participants, none were
areca quid chewers (1 quid or more daily for at least 1
year), 34 (25.0%) were smokers (1 cigarette(s) or more per
day for at least 1 year), and 23 (16.9%) were drinkers
(drinking > 3 days a week).
The blood samples were drawn from all OSF patients and
healthy control participants for measurement of complete
blood count, blood iron, vitamin B12, and folic acid con-
centrations. In addition, the presence of GPCA in sera of
OSF patients and healthy control participants was also
checked. All OSF patients and healthy control participants
signed the informed consents prior to entering the study.
This study was reviewed and approved by the Institutional
Review Board at the NTUH.Determination of complete blood count and blood
iron, vitamin B12, and folic acid concentrations
The complete blood count and blood iron, vitamin B12, and
folic acid concentrations were determined using routine
tests performed in the Department of Laboratory Medicine
of NTUH.31e37Determination of serum GPCA level
The serum GPCA level was detected using the indirect
immunofluorescence technique with rat stomach as a
substrate as described previously.36,37 In brief, 5-mm-
thick cryostat sections of substrate tissues on slides
were reacted with serially diluted patients’ and control
participants’ sera in a moist chamber at room temper-
ature for 30 minutes. The initial dilution of the pa-
tients’ and control participants’ sera was 1:20 with
phosphate-buffered saline. After washing, the sections
were incubated with fluorescein isothiocyanate-labeled
goat antihuman immunoglobulin G antiserum (Boeh-
ringer Mannheim Biochemicals, Indianapolis, IN, USA),
which had been prediluted and kept in dropper vial by
the manufacturer and was ready to use for another 30
minutes. The sections were washed again, mounted
with buffered glycerine, and examined with an Olympus
fluorescence microscope (Olympus, Tokyo, Japan). Sera
were scored as positive when they produced fluores-
cence at a dilution of  20-fold.Statistical analysis
Comparisons of the MCV and mean blood levels of Hb, iron,
vitamin B12, and folic acid between 68 OSF patients and 136
age-matched healthy control participants were performed
using Student t test. The differences in frequency of Hb,
iron, vitamin B12, or folic acid deficiency or of serum GPCA
positivity between 68 OSF patients and 136 age-matched
healthy control participants were compared using the Chi-
square test. The result was considered to be significant if
p < 0.05.Results
The mean MMO of 68 OSF patients was 30.7  8.0 mm; 33
had an MMO of  31 mm and 35 had an MMO of > 31 mm.
The soft palate, retromolar area, and buccal mucosa were
the three sites involved by OSF in every patient, with extra
involvement of labial mucosa in 41 patients (60.3%), of floor
of the mouth in 33 patients (48.5%), and of tongue in 27
patients (39.7%). Of the 68 OSF patients, 16 had three-site
involvement, 18 had four-site involvement, 19 had five-site
involvement, and 15 had six-site involvement by OSF.
The MCV and mean blood concentrations of Hb, iron,
vitamin B12, and folic acid in 68 male OSF patients and in
136 age-matched male healthy control individuals are
shown in Table 1. We found that OSF patients had a
significantly lower mean serum vitamin B12 level (p < 0.001)
and a significantly lower mean serum folic acid level
(p < 0.001) than healthy control participants (Table 1).
However, there were no differences in the MCV and mean
Hb and serum iron levels between 68 OSF patients and 136
age-matched healthy control participants (Table 1).
According to the World Health Organization (WHO)
criteria, men with Hb < 13 g/dL were defined as having Hb
deficiency or anemia.38 For serum iron, vitamin B12, and
folic acid levels, this study chose the serum iron
level  70 mg/dL for men as the iron deficiency level, the
serum vitamin B12 level  450 pg/mL as the vitamin B12
deficiency level, and the folic acid level  6 ng/mL as the
folic acid deficiency level.39,40 These iron, vitamin B12, and
folic acid concentrations were chosen because they were
the cutoff point concentrations for giving the iron, vitamin
B12, and folic acid supplement treatment to oral mucosal
disease patients with iron, vitamin B12, or folic acid defi-
ciency.39,40 By the above-mentioned definitions, five
(7.4%), 14 (20.6%), 34 (50.0%), and 28 (41.2%) of the 68 OSF
patients had Hb, iron, vitamin B12, and folic acid de-
ficiencies, respectively. Moreover, nine (13.2%) OSF pa-
tients had serum GPCA positivity (Table 2). However, none
(0%), 20 (14.7%), 30 (22.1%), eight (5.9%), and four (2.9%) of
normal control participants had Hb, iron, vitamin B12, and
folic acid deficiencies and serum GPCA positivity by the
aforementioned criteria, respectively. Furthermore, OSF
patients had a significantly higher frequency of Hb
(p Z 0.006), vitamin B12 (p < 0.001), or folic acid
(p < 0.001) deficiency and of serum GPCA positivity
(p Z 0.011) than healthy control participants (Table 2).
Furthermore, 19 of the 68 OSF patients had no hematinic
deficiency. Of the resting 49 OSF patients, 26 had single
hematinic deficiency (iron, 3 patients; vitamin B12, 13
Table 1 The mean corpuscular volume (MCV) and mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, and folic
acid in 68 male patients with oral submucous fibrosis (OSF) and in 136 age-matched male healthy control participants.
OSF patients (n Z 68) Healthy control participants (n Z 136) p
(Student t test)Mean  SD Range Mean  SD Range
Hb (g/dL) 15.2  1.7 6.8e18.5 15.3  0.9 13.8e16.9 0.583
MCV (fl) 91.4  8.0 63.0e114.3 90.8  3.2 82.4e98.6 0.447
Iron (mg/dL) 114.2  49.9 21.0e279.0 115.3  24.8 65.0e151.0 0.833
Vitamin B12 (pg/mL) 510.9  219.0 107.5e1000.0 652.8  225.3 259.0e1000.0 < 0.001*
Folic acid (ng/mL) 7.0  2.8 2.0e15.4 13.8  6.2 4.1e24.0 < 0.001*
SD Z standard deviation.
* Comparisons of MCV and blood concentrations of Hb, iron, vitamin B12, and folic acid between 68 male OSF patients and 136 age-
matched male healthy control participants by Student t test with p < 0.001.
Table 2 Number and percentage of individuals with hemoglobin (Hb), iron, vitamin B12, or folic acid deficiency or with serum
gastric parietal cell antibody (GPCA) positivity in 68 male patients with oral submucous fibrosis (OSF) and in 136 age-matched
male healthy control participants.
Factor Participant number (%) p
(Chi-square test)OSF patients (n Z 68) Healthy control participants
(n Z 136)
Hb deficiency (< 13 g/dL) 5 (7.4) 0 (0) 0.006*
Iron deficiency ( 70 mg/dL) 14 (20.6) 20 (14.7) 0.388
Vitamin B12 deficiency ( 450 pg/mL) 34 (50.0) 30 (22.1) <0.001*
Folic acid deficiency ( 6 ng/mL) 28 (41.2) 8 (5.9) <0.001*
GPCA positivity 9 (13.2) 4 (2.9) 0.011*
* Comparison of frequency of Hb, iron, vitamin B12, or folic acid deficiency or of serum GPCA positivity between 68 male patients with
oral submucous fibrosis and in 136 age-matched male healthy control participants by chi-square test with p < 0.05.
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matinic deficiencies (iron and vitamin B12, 5 patients; iron
and folic acid, 2 patients; and vitamin B12 and folic acid, 12
patients), and four had triple hematinic (iron, vitamin B12,
and folic acid) deficiencies.
Of the five OSF patients with anemia (Table 3), two had
thalassemia trait (Patient 1 also had vitamin B12 and folic
acid deficiencies),32 one had iron deficiency anemia,34 and
two had macrocytic anemia (MCV  100 fL; Patient 4 also
had iron, vitamin B12, and folic acid deficiencies).
37 All five
OSF patients were serum GPCA-negative. Moreover, anemia
was found in two of four OSF patients with macrocytosis
(MCV  100 fL) and three of five OSF patients with micro-
cytosis (MCV < 80 fL; Table 3).Table 3 Diagnosis, hemoglobin (Hb), mean corpuscular volume
vitamin B12 level, serum folic acid level, and serum gastric parieta
anemia (Hb < 13 g/dL).
Patient
No.
Diagnosis Hb
(g/dL)
MCV
(fL)
RBC
(1012/L)
M
(
1 Thalassemia trait 12.4 70.2 5.57 1
2 Thalassemia trait 12.4 63.0 5.92 1
3 Iron deficiency anemia 6.8 69.2 3.70 1
4 Macrocytic anemia 10.0 114.3 2.59 4
5 Macrocytic anemia 12.5 101.1 3.74 2Of the nine OSF patients with serum GPCA positivity, six
had vitamin B12 deficiency, five had folic acid deficiency,
and two had iron deficiency (Table 4). However, none of the
nine GPCA-positive OSF patients had pernicious anemia
based on the strict WHO definitions (Hb < 13 g/dL for men
and < 12 g/dL for women, MCV  100 fL, serum vitamin
B12 < 200 pg/mL, and serum GPCA-positive; Table 4).
36Discussion
This study found that five (7.4%), 14 (20.6%), 34 (50.0%), 28
(41.2%), and nine (13.2%) of the 68 male OSF patients had
Hb, iron, vitamin B12, and folic acid deficiencies, and serum(MCV), red blood cell (RBC) number, serum iron level, serum
l cell antibody (GPCA) positivity in five male OSF patients with
entzer index
MCV/RBC)
Iron
(mg/dL)
Vitamin B12
(pg/mL)
Folic acid
(ng/mL)
GPCA
positivity
2.6 130 449 6.0 d
0.6 126 770 8.3 d
8.7 21 452 6.2 d
4.1 37 228 4.8 d
7.0 109 678 15.4 d
Table 4 Hemoglobin (Hb), mean corpuscular volume (MCV), red blood cell (RBC) number, serum iron level, serum vitamin B12
level, and serum folic acid level in nine male OSF patients with serum gastric parietal cell antibody (GPCA) positivity.
Patient No. Hb (g/dL) MCV (fl) RBC ( 1012/L) Iron (mg/dL) Vitamin B12 (pg/mL) Folic acid (ng/mL) GPCA positivity
1 15.4 93.9 5.06 95 486.1 8.3 þ
2 14.5 94.0 4.64 95 107.5 5.7 þ
3 14.8 93.5 4.64 174 429 8.1 þ
4 15.8 99.4 4.75 58 291 4.1 þ
5 14.8 90.6 4.91 85 222 6.8 þ
6 13.6 97.1 4.13 54 812 3.3 þ
7 15.0 94.7 4.86 111 274 3.1 þ
8 15.9 95.9 4.84 128 295 14.1 þ
9 14.6 89.1 4.85 119 775 3.6 þ
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had a significantly higher frequency of Hb, vitamin B12, or
folic acid deficiency and of serum GPCA positivity than
healthy control participants. In addition, single hematinic
deficiency and multiple hematinic deficiencies were found
in 26 (38.2%) and 23 (33.8%) of the 68 OSF patients,
respectively. These findings suggest that hematinic de-
ficiencies are frequently found in OSF patients. Because all
of our OSF patients had moderate or severe OSF with the
mean MMO being 30.7 mm, it was possible that the Hb, iron,
vitamin B12, and folic acid deficiencies were at least
partially attributable to difficult and insufficient food
intake secondary to the limited mouth opening and intol-
erance to spicy food in OSF patients. Wahi et al41 also re-
ported a significantly higher prevalence of malnutrition in
104 OSF patients than in 200 normal control participants. In
their study, poor nutritional status was evident on clinical
examination in 28% of the 70 male and 35% of the 34 female
OSF patients. In addition, of 104 OSF patients, 40 (38.5%)
had multiple vitamin deficiencies, 20 (19.2%) had vitamin A
deficiency, 56 (53.8%) had vitamin B deficiency, and 54
(51.9%) had vitamin C deficiency.41
Ramanathan42 reported that five (63%) of the eight OSF
patients have a depressed serum iron level below the
normal value. Rajendran et al43 found a significantly lower
serum iron level in 50 OSF patients than in 50 age- and sex-
matched control participants. Anuradha and Devi44 attrib-
uted the deficiencies of vitamin C and iron in 36 OSF pa-
tients to the increased utilization of these two substances
in collagen synthesis. Tadakamadla et al45 discovered a
significantly higher mean serum copper level and a signifi-
cantly lower mean serum iron level in 50 OSF patients than
in 50 age- and sex-matched control participants. However,
there was no significant difference in the mean serum iron
level between 68 male OSF patients and 136 age-matched
male healthy control participants in the present study.
Ramanathan42 reported that 10 (77%) of the 13 OSF pa-
tients in Malaysia have iron deficiency anemia. The present
study showed anemia in five (7.4%) of the 68 OSF patients
and a significantly greater frequency of anemia in 68 OSF
patients than in 136 healthy control participants. Wahi
et al41 discovered that 6% of the 70 male OSF patients and
11% of the 34 female OSF patients had anemia, but the
frequency of anemia did not differ significantly from that of
the control participants. A South African study also found
no significant difference in the prevalence of irondeficiency anemia between OSF patients and the general
population.46
In a South African study, Seedat46 reported that serum
vitamin B12 and folate levels of OSF patients are within
normal limits. However, Ramanathan42 found folic acid
deficiency in six of the six OSF patients. This study also
discovered that 34 (50.0%) and 28 (41.2%) of OSF patients
had vitamin B12 and folic acid deficiencies, respectively.
Only six of the 34 vitamin B12-deficient OSF patients were
GPCA-positive. In these six GPCA-positive OSF patients, the
vitamin B12 deficiency could be attributed to the presence
of GPCA, because GPCA can induce destruction of parietal
cells and in turn result in failure of intrinsic factor pro-
duction.47,48 Lack of intrinsic factor finally leads to failure
of vitamin B12 absorption.
49,50 Furthermore, the vitamin B12
deficiency in the other 28 GPCA-negative OSF patients may
be attributable to other causes including inadequate intake
or malabsorption of vitamin B12, the presence of anti-
intrinsic factor antibodies, or transcobalamin II defi-
ciency.50 Folic acid deficiency may result from poor nutri-
tional intake, malabsorption, hepatobiliary dysfunction,
increased folate catabolism, and medication (e.g., meth-
otrexate, 5-fluoro-uracil, phenytoin).50 In the present
study, we suggest that the folic acid deficiency is probably
due to poor or insufficient intake of folic acid-containing
diet because OSF patients usually have functional impair-
ment in food intake and chewing. Further studies are
necessary to explore the real causes resulting in vitamin B12
and folic acid deficiencies in OSF patients.
Our previous study demonstrated that 14.7% of 109 male
OSF patients are GPCA-positive.6 A similar result was found
in this study, showing serum GPCA positivity in nine (13.2%)
of 68 male OSF patients. Although six of the nine GPCA-
positive OSF patients had vitamin B12 deficiency in this
study, none of these six OSF patients had pernicious anemia
by the strict WHO definitions.36 Our previous studies also
found that only 12.9% of 124 GPCA-positive,36 18.9% of 90
vitamin B12-deficient (unpublished data), and 16.7% of 60
macrocytosis patients with oral mucosal diseases had per-
nicious anemia based on the strict WHO definitions.37
Our results demonstrated that five (7.4%), 14 (20.6%), 34
(50.0%), 28 (41.2%), and nine (13.2%) of the 68 male OSF
patients had Hb, iron, vitamin B12, and folic acid de-
ficiencies, and serum GPCA positivity, respectively.
Furthermore, OSF patients had a significantly higher fre-
quency of Hb, vitamin B12, or folic acid deficiency and of
818 Y.-P. Wang et al.serum GPCA positivity than healthy control participants.
We conclude that there are high frequencies of vitamin B12
and folic acid deficiencies and of serum GPCA positivity in
our OSF patients.
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